Clinical Trials : Asia-Pacific Perspective
Speaker: NADINA C. JOSE
The Asia Pacific region is a dynamic emerging market with two of the world’s largest populations; India with 1.2 billion and China with another 1.3 billion. According to clinicaltrials.gov, there are currently 14, 825 trials being conducted in the Asia Pacific region. More and more clinical trials are now shifting to Asia Pacific region which is perhaps the most diverse region in terms of cultures, populations, education, healthcare and drug regulatory policies.
With the current global economy in turmoil, global Asians previously based in the US and EU have chosen to reinvent themselves in APAC countries they originated from. China, Taiwan, Korea, Singapore, Philippines, Thailand and Vietnam are the top 7 countries where reverse migration has been on the rise. Concurrently, noted US institutions like John Hopkins, Duke, and The Cleveland Clinic to name a few have formed significant strategic alliances with major internationally accredited and recognized universities and institutions in the region. This current migratory back flow has provided motivated physicians and specialists to ride this current trend to think about giving back to their former countrymen by providing expertise that otherwise was not readily available to many.
This webinar will discuss current conditions and will share lessons learned and best practices in conducting clinical trials in the Asia Pacific region.
Webinar: From your own Desk (Internet connection and head set / speakers)
Who should participate? Clinical Operation, Medical Directors, Investigators, QA, Regulatory and all other clinical professionals
Limited Participants: Maximum 50 only
MakroCare is an international drug development partner that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction. MakroCare has 4 subsidiaries/divisions – CRO, Consulting, SMO and Informatics. MakroCare has teams positioned worldwide in these divisions supporting start from clinical to commercializing, regulatory affairs, risk management, trial management (clinical, late phase), monitoring, biometrics (CDM, EDC, Biostatistics, SAS programming, medical writing), QA audits, drug safety / Pharmacovigilance, site management, patient recruitment, informatics (EDC, CTMS, IVRS), contact center and various aspects of drug development.